Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson's disease.
<h4>Objective</h4>To clarify whether antiparkinsonian drugs contribute to nocturnal sleep disturbances in patients with Parkinson's disease (PD).<h4>Background</h4>Although the major antiparkinsonian drugs L-dopa and dopamine agonists (DAs) have been found to affect slee...
Guardado en:
Autores principales: | Soutarou Taguchi, Hirofumi Koide, Hiroko Oiwa, Miku Hayashi, Kazuhiro Ogawa, Chihiro Ito, Koji Nakashima, Tomoko Yuasa, Akihiro Yasumoto, Hiroaki Ando, Akifumi Fujikake, Takaaki Fukuoka, Keisuke Tokui, Masayuki Izumi, Yuka Tsunoda, Yuichi Kawagashira, Yohei Okada, Jun-Ichi Niwa, Manabu Doyu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e8ffd43dcce34cb4b784d0d96a8bc379 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Contributors
por: HUB de diseño social
Publicado: (2019) -
Guide for Contributors
por: Editorial Board
Publicado: (2021) -
Information for contributors and readers for the issue 1-2021
por: Nebojša N. Gaćeša
Publicado: (2021) -
Information for contributors and readers for issue 4-2020
por: Nebojša N. Gaćeša
Publicado: (2020) -
Genetic and immunological contributors to virus-induced paralysis
por: Aracely A. Perez Gomez, et al.
Publicado: (2021)